Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f9468292f7484ade8b7255433d01633b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f9468292f7484ade8b7255433d01633b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f9468292f7484ade8b7255433d01633b2021-11-12T04:43:12ZAdvantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data1663-981210.3389/fphar.2021.733526https://doaj.org/article/f9468292f7484ade8b7255433d01633b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.733526/fullhttps://doaj.org/toc/1663-9812This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.Nevena SkrozaErsilia TolinoVeronica BalduzziNicoletta BernardiniAlessandra MambrinAnna MarchesielloFederica MarraffaGiovanni RossiSalvatore VolpeIlaria ProiettiConcetta PotenzaFrontiers Media S.A.articleisotretinoinefficacysafetyacne severitygenderTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
isotretinoin efficacy safety acne severity gender Therapeutics. Pharmacology RM1-950 |
spellingShingle |
isotretinoin efficacy safety acne severity gender Therapeutics. Pharmacology RM1-950 Nevena Skroza Ersilia Tolino Veronica Balduzzi Nicoletta Bernardini Alessandra Mambrin Anna Marchesiello Federica Marraffa Giovanni Rossi Salvatore Volpe Ilaria Proietti Concetta Potenza Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
description |
This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events. |
format |
article |
author |
Nevena Skroza Ersilia Tolino Veronica Balduzzi Nicoletta Bernardini Alessandra Mambrin Anna Marchesiello Federica Marraffa Giovanni Rossi Salvatore Volpe Ilaria Proietti Concetta Potenza |
author_facet |
Nevena Skroza Ersilia Tolino Veronica Balduzzi Nicoletta Bernardini Alessandra Mambrin Anna Marchesiello Federica Marraffa Giovanni Rossi Salvatore Volpe Ilaria Proietti Concetta Potenza |
author_sort |
Nevena Skroza |
title |
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
title_short |
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
title_full |
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
title_fullStr |
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
title_full_unstemmed |
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data |
title_sort |
advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/f9468292f7484ade8b7255433d01633b |
work_keys_str_mv |
AT nevenaskroza advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT ersiliatolino advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT veronicabalduzzi advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT nicolettabernardini advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT alessandramambrin advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT annamarchesiello advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT federicamarraffa advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT giovannirossi advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT salvatorevolpe advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT ilariaproietti advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata AT concettapotenza advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata |
_version_ |
1718431265508556800 |